Literature DB >> 19201608

Glucocorticoids may trigger attacks in several types of periodic paralysis.

Marianne Arzel-Hézode1, Suzanne McGoey, Damien Sternberg, Savine Vicart, Bruno Eymard, Bertrand Fontaine.   

Abstract

Hypokalemic periodic paralysis is a rare disorder characterized by episodic attacks of muscle flaccidity associated with low serum potassium levels. We report twelve patients with normokalemic and hypokalemic periodic paralysis due to various mutations who developed hypokalemic paralytic episodes following a single dose or short-term administration of glucocorticoids. We hypothesize that glucocorticoids cause hypokalemia due to their stimulation of the Na(+)-K(+) ATPase mediated by insulin and amylin and due to their side effect of insulin resistance resulting in hyperglycemia. This report adds to the clinical description of glucocorticoids as a trigger of attacks of hypokalemic periodic paralysis indicating that glucocorticoids should be administered with caution in patients with periodic paralysis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19201608     DOI: 10.1016/j.nmd.2008.12.008

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  4 in total

1.  Sodium and chloride channelopathies with myositis: coincidence or connection?

Authors:  Emma Matthews; James A L Miller; Malcolm R MacLeod; James Ironside; Gareth Ambler; Robin Labrum; Richa Sud; Janice L Holton; Michael G Hanna
Journal:  Muscle Nerve       Date:  2011-06-22       Impact factor: 3.217

2.  Intra-abdominal hypertension in patients with sellar region tumors.

Authors:  Konstantin A Popugaev; Ivan A Savin; Andrew U Lubnin; Alexander S Goriachev; Boris A Kadashev; Pavel L Kalinin; Andrew V Oshorov; Alexander A Polupan; Ekaterina U Sokolova; Maxim A Kutin; Valeriy I Lukianov
Journal:  Ann Intensive Care       Date:  2012-07-05       Impact factor: 6.925

Review 3.  Physiological and Pathophysiological Insights of Nav1.4 and Nav1.5 Comparison.

Authors:  Gildas Loussouarn; Damien Sternberg; Sophie Nicole; Céline Marionneau; Francoise Le Bouffant; Gilles Toumaniantz; Julien Barc; Olfat A Malak; Véronique Fressart; Yann Péréon; Isabelle Baró; Flavien Charpentier
Journal:  Front Pharmacol       Date:  2016-01-14       Impact factor: 5.810

4.  Substitutions of the S4DIV R2 residue (R1451) in NaV1.4 lead to complex forms of paramyotonia congenita and periodic paralyses.

Authors:  Hugo Poulin; Pascal Gosselin-Badaroudine; Savine Vicart; Karima Habbout; Damien Sternberg; Serena Giuliano; Bertrand Fontaine; Saïd Bendahhou; Sophie Nicole; Mohamed Chahine
Journal:  Sci Rep       Date:  2018-02-01       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.